Literature DB >> 23995396

Development of a modified sampling and calculation method for isotope plasma clearance assessment of the glomerular filtration rate in patients with cirrhosis and ascites.

Fred Wickham1, Maria T Burniston, Elias Xirouchakis, Eleni Theocharidou, Carl A Wesolowski, Andrew J W Hilson, Andrew K Burroughs.   

Abstract

AIM: The aim of this study was to identify a practical sampling regimen and calculation method that could be used to measure the glomerular filtration rate in patients with ascites using plasma sampling. PATIENTS AND METHODS: Thirteen potential liver transplant patients with cirrhosis and ascites were injected with Cr-51 ethylenediaminetetraacetic acid, and plasma samples were obtained at up to 16 time points for each patient. Reference clearance values were calculated using the area under the plasma clearance curve, which was calculated using all the available data points. Clearance calculations were then performed using three and four data points from each patient and three different calculation methods to identify a sampling regimen and calculation method that yielded good agreement with the reference values.
RESULTS: The reference clearances ranged from 6 to 80 ml/min. Sampling at 2, 4, 8 and 24 h and calculation of the area under the plasma clearance curve using a log-linear trapezoidal rule with extrapolation to zero and infinity yielded a relative root mean square difference from the reference of less than 7%.
CONCLUSION: This method for measuring glomerular filtration rate in patients with cirrhosis and ascites was found to be more accurate than the slope-intercept technique and is a practical alternative to urine collection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995396     DOI: 10.1097/MNM.0b013e32836529ab

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  5 in total

1.  The early plasma concentration of 51Cr-EDTA in patients with cirrhosis and ascites: a comparison of three models.

Authors:  Surajith N Wanasundara; Michal J Wesolowski; Richard C Puetter; Maria T Burniston; Elias Xirouchakis; Ioannis G Giamalis; Paul S Babyn; Carl A Wesolowski
Journal:  Nucl Med Commun       Date:  2015-04       Impact factor: 1.690

2.  Accurate and precise plasma clearance measurement using four 99mTc-DTPA plasma samples over 4 h.

Authors:  Surajith N Wanasundara; Michal J Wesolowski; Mark C Barnfield; Michael L Waller; Anthony W Murray; Maria T Burniston; Paul S Babyn; Carl A Wesolowski
Journal:  Nucl Med Commun       Date:  2016-01       Impact factor: 1.690

3.  A gamma-distribution convolution model of 99mTc-MIBI thyroid time-activity curves.

Authors:  Carl A Wesolowski; Surajith N Wanasundara; Michal J Wesolowski; Belkis Erbas; Paul S Babyn
Journal:  EJNMMI Phys       Date:  2016-12-16

4.  Comparison of the gamma-Pareto convolution with conventional methods of characterising metformin pharmacokinetics in dogs.

Authors:  Carl A Wesolowski; Surajith N Wanasundara; Paul S Babyn; Jane Alcorn
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-12-21       Impact factor: 2.745

Review 5.  Assessment of kidney function: clinical indications for measured GFR.

Authors:  Natalie Ebert; Sebastjan Bevc; Arend Bökenkamp; Francois Gaillard; Mads Hornum; Kitty J Jager; Christophe Mariat; Bjørn Odvar Eriksen; Runolfur Palsson; Andrew D Rule; Marco van Londen; Christine White; Elke Schaeffner
Journal:  Clin Kidney J       Date:  2021-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.